Ligand validation:2PHU

MAN: alpha-D-mannopyranose

MAN is a Ligand Of Interest in 2PHU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2PHU_MAN_A_253	91%	74%	0.067	0.97	0.49	0.51	-	-	0	0	92%	1
2ARE_MAN_B_253	92%	84%	0.075	0.966	0.42	0.34	-	-	1	1	100%	1
2GN3_MAN_A_300	78%	77%	0.069	0.924	0.43	0.48	-	-	1	0	92%	1
2GND_MAN_B_253	73%	80%	0.087	0.913	0.45	0.4	-	-	2	0	100%	1
2GNB_MAN_A_300	59%	81%	0.095	0.877	0.45	0.37	-	-	0	0	100%	1
2GNM_MAN_A_253	19%	87%	0.195	0.787	0.36	0.33	-	-	0	0	100%	0.5
5O2X_MAN_A_311	100%	66%	0.023	0.995	0.37	0.94	-	1	0	0	100%	1
7C3C_MAN_A_401	100%	65%	0.039	0.988	0.72	0.62	-	-	0	0	100%	1
5JUG_MAN_A_202	100%	57%	0.038	0.985	0.44	1.2	-	1	0	0	100%	0.4
1GAI_MAN_A_480	100%	75%	0.043	0.986	0.45	0.53	-	-	0	0	100%	1
5AGD_MAN_B_500	100%	38%	0.041	0.982	0.53	1.88	-	4	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.